Analysts’ Recent Ratings Updates for FIGS (FIGS)

A number of research firms have changed their ratings and price targets for FIGS (NYSE: FIGS):

• 11/11/2026 – FIGS was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 11/10/2026 – FIGS is now covered by Cantor Fitzgerald. They set an “overweight” rating and a $25.00 price target on the stock.
• 11/7/2026 – FIGS was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 11/6/2026 – FIGS had its price target raised by KeyCorp from $20.00 to $27.00. They now have an “overweight” rating on the stock.
• 11/3/2026 – FIGS had its price target raised by Barclays from $20.00 to $24.00. They now have an “overweight” rating on the stock.
• 10/30/2026 – FIGS had its price target raised by BTIG Research from $22.00 to $25.00. They now have a “buy” rating on the stock.
• 10/29/2026 – FIGS had its price target raised by Oppenheimer from $22.00 to $25.00. They now have an “outperform” rating on the stock.
• 10/27/2026 – FIGS was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 10/12/2026 – FIGS was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 10/10/2026 – FIGS was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 9/19/2026 – FIGS was downgraded by Wall Street Zen from “strong-buy” to “buy”.

FIGS Stock Down 2.9%

NYSE FIGS opened at $22.73 on Friday. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of 59.81 and a beta of 1.05. The business has a 50-day moving average price of $16.92 and a 200-day moving average price of $13.86. FIGS, Inc. has a twelve month low of $8.95 and a twelve month high of $23.76.

FIGS (NYSE:FIGS) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.03. FIGS had a return on equity of 14.65% and a net margin of 9.67%. The company had revenue of $190.69 million for the quarter, compared to analysts’ expectations of $182.82 million. During the same period in the previous year, the firm earned $0.05 EPS. The firm’s revenue was up 25.7% compared to the same quarter last year. Research analysts expect that FIGS, Inc. will post 0.35 EPS for the current fiscal year.

Insiders Place Their Bets

In other FIGS news, CEO Catherine Spear sold 4,044,284 shares of the stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $19.70, for a total transaction of $79,672,394.80. Following the completion of the transaction, the chief executive officer owned 1,671,854 shares of the company’s stock, valued at $32,935,523.80. This represents a 70.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Sarah Oughtred sold 90,000 shares of the firm’s stock in a transaction dated Wednesday, November 11th. The shares were sold at an average price of $21.92, for a total value of $1,972,800.00. Following the transaction, the chief financial officer owned 954,007 shares of the company’s stock, valued at approximately $20,911,833.44. The trade was a 8.62% decrease in their position. The disclosure for this sale is available in the SEC filing. 27.06% of the stock is currently owned by corporate insiders.

FIGS, Inc. designs and sells apparel and accessories for healthcare professionals. Its products include scrubs, underscrubs, lab coats, outerwear, footwear, compression socks and other work-related accessories, with an emphasis on functional design and performance fabrics. The company primarily sells through its e-commerce platform, serving healthcare workers in the United States and internationally. Its offerings are aimed at professionals across a range of medical roles and care settings. FIGS was founded in 2013 by Heather Hasson and Trina Spear.